Cargando…
High Expression of RhoF Predicts Worse Overall Survival: A Potential Therapeutic Target for non-M3 Acute Myeloid Leukemia: Erratum
Autores principales: | Hou, Yue, Zi, Jie, Ge, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197945/ https://www.ncbi.nlm.nih.gov/pubmed/37215457 http://dx.doi.org/10.7150/jca.85287 |
Ejemplares similares
-
High Expression of RhoF Predicts Worse Overall Survival: A Potential Therapeutic Target for non-M3 Acute Myeloid Leukemia
por: Hou, Yue, et al.
Publicado: (2021) -
Erratum to: Genetic alterations of m(6)A regulators predict poorer survival in acute myeloid leukemia
por: Kwok, Chau-To, et al.
Publicado: (2017) -
Erratum to “Prognostic factors affecting disease-free survival and overall survival in T4 colon cancer”
Publicado: (2023) -
Erratum to “A Case of Abdominal Sarcoidosis in a Patient with Acute Myeloid Leukemia”
por: Baskaran, Vadsala, et al.
Publicado: (2013) -
Erratum: PTEN deletion drives acute myeloid leukemia resistance to MEK inhibitors
por: Smith, Amanda M., et al.
Publicado: (2020)